Sign in

CIK 0001896212

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

CDT Equity Inc.

Sign in to watch
Ticker
CDT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
873272543
Phone
+1 646-491-9132
Business address
4851 TAMIAMI TRAIL NORTH, SUITE 200, NAPLES, FL, 34103
Former names
CONDUIT PHARMACEUTICALS INC., Murphy Canyon Acquisition Corp.

Securities

  • CDT Common Stock Nasdaq
  • CDTTW Warrant Nasdaq
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 2 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-10-23 Regan Andrew 10% owner Other acquisition +499,616 499,618
2026-10-22 Regan Andrew 10% owner Other acquisition +1,347,616 1,347,619
2026-08-28 Regan Andrew Chief Executive Officer Other acquisition +543,683 569,322
2026-08-28 Regan Andrew Chief Executive Officer Sale −29 569,322
2026-08-28 Regan Andrew Chief Executive Officer Option exercise · Pre-Funded Warrants −543,683 $0.00 $54 0
2026-08-28 Regan Andrew Chief Executive Officer Other acquisition +5,436,830 5,693,223
2026-08-28 Regan Andrew Chief Executive Officer Sale −290 5,692,933
2026-08-28 Regan Andrew Chief Executive Officer Option exercise · Pre-Funded Warrants −5,436,830 $0.00 $544 0
2026-07-30 Regan Andrew Chief Executive Officer Other acquisition · Pre-Funded Warrants +5,436,830 $0.00 $544 543,683
2026-07-30 Regan Andrew Chief Executive Officer Other acquisition · Pre-Funded Warrants +5,436,830 $0.00 $544 5,436,830
2026-05-13 Regan Andrew Chief Executive Officer Grant or award +100,000 $1.90 $190K 256,393
2026-03-24 Regan Andrew Chief Executive Officer Grant or award +147,401 156,393
2026-03-24 Regan Andrew Chief Executive Officer Conversion · Pre-Funded Warrants −147,401 $0.00 $15 0
2025-12-08 Regan Andrew Chief Executive Officer Grant or award +224,800 $1.79 $402K 227,304
2025-12-08 Regan Andrew Chief Executive Officer Grant or award · Pre-Funded Warrants +3,685,815 $0.00 $369 3,685,815
2025-09-19 Regan Andrew Chief Executive Officer Grant or award +1,120,000 $0.69 $769K 1,120,044
2025-06-03 Regan Andrew Chief Executive Officer Grant or award +154,799 $3.23 $500K 154,799
2024-07-17 Regan Andrew Director Sale −1,514,100 $0.26 $391K 177,627
2024-07-16 Regan Andrew Director Sale −10,244,392 $0.32 $3.2M 1,691,727
2024-07-15 Regan Andrew Director Sale −1,005,200 $0.25 $248K 11,936,119

Page 1 of 2 · 29 trades